Alebund Pharmaceuticals (Jiangsu) Limited (HKG:9637)

Market Cap	10.18B
Revenue (ttm)	34.00M +368.3%
Net Income	-834.65M
EPS	-3.42
Shares Out	339.85M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,000
Open	29.20
Previous Close	29.96
Day's Range	28.96 - 29.92
52-Week Range	22.60 - 46.82
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About HKG:9637

Alebund Pharmaceuticals (Jiangsu) Limited operates as a biopharmaceutical company that develops therapies for kidney diseases and their complications in China and Hong Kong. Its products include AP301, a phosphate binder; AP306, a sodium-dependent phosphate transport protein inhibitor; one early-clinical-stage product candidate AP303; and four preclinical product candidates, including AP308, AP304, AP305, and AP307. Alebund Pharmaceuticals (Jiangsu) Limited was founded in 2018 and is headquartered in Yangzhou, China.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2018
• Country: China
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 9637

Financial Performance

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 16, 2026

Data Sources Report a data error